Cartesian Therapeutics, Inc 10-K for FY2023
Cartesian Therapeutics, Inc. (RNAC)
10-K
2024-03-07
For: 2023-12-31
View Original
Added on
April 08, 2026
About this 10-K
Cartesian Therapeutics, Inc filed this 10-K on March 7, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $26M
- down 76.5% from $110.78M a year earlier
- Net loss
- $219.71M
- compared with net income of $35.38M a year earlier
- Diluted EPS
- -$1.66
- compared with $0.10 a year earlier